JMP Securities analyst Reni Benjamin maintained a Buy rating on Blueprint Medicines (BPMC – Research Report) today and set a price target of ...
JMP Securities analyst Matthew Carletti reiterated a Buy rating on Kemper (KMPR – Research Report) today and set a price target of $85.00. The ...
1d
Stocktwits on MSNAviat Networks Stock Soars Pre-Market As JMP Maintains Positive Outlook: Retail Stays Bearish On Mixed ResultsShares of Aviat Networks Inc. (AVNW) surged over 19% during pre-market trade on Wednesday as analysts at JMP Securities ...
The web services and cybersecurity specialist's share price ended the day's trading up 10.7% amid the backdrop of a 0.8% gain for the S&P 500 index and a 2% jump for the Nasdaq Composite index.
JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...
Ironwood Pharmaceuticals (NASDAQ:IRWD – Free Report) had its price objective decreased by JMP Securities from $23.00 to $14.00 in a research note issued to investors on Thursday morning ...
JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...
Unity Software (NYSE:U – Get Free Report)‘s stock had its “market perform” rating reissued by research analysts at JMP ...
JMP Securities raised the firm’s price target on Sportradar (SRAD) to $19 from $17 and keeps an Outperform rating on the shares. During the current NFL season, bettors experienced one of the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results